William Blair & Company’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
MF
VI
FLAM
AAM
RSCM
William Blair & Company's XENT Position: Q3 2021 in Review
William Blair & Company sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 29,564 shares — an estimated $505K sold.
William Blair & Company first reported a position in XENT in Q2 2015 and held it in 25 quarters. The position peaked at $3.25M in Q3 2015. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.
- William Blair & Company reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
- William Blair & Company sold 29,564 Intersect ENT, Inc shares in Q3 2021, an estimated $505K.
- William Blair & Company first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 25 quarters.
- William Blair & Company's Intersect ENT, Inc position peaked at $3.25M in Q3 2015.
- 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.
Based on William Blair & Company's 13F filing for Q3 2021, filed 12 Nov 2021.